The short answer is: there is a difference. There has been a slight bit of confusion about the three conditions and therefore this blog entry is an attempt at a brief clarification.
HISTAMINE INTOLERANCE (HIT) aka Histamine Intolerance Syndrome (HIS)
is a condition which is first and foremost a deficiency of either or both enzymes DAO (diamine oxidase) and histamine N-methyltransferase after the ingestion of food high in histamine. This is because a person is either unable to produce enough enzymes or because one or both enzymes have been inhibited by different causes. There are many reasons why this could have happened and it is down to each individual to find out the underlying cause. Some examples of causes (and the list is long…) could be an underlying condition such as an infection in the intestinal area, another food intolerance causing diarrhoea, an allergy or mastocytosis.
In the case of allergies, histamine is released by the body as part of an excessive immune system response to a normally harmless substance like pollen or certain foods or drugs. Cross-reactivity in people who are allergic to certain pollens or other substances also plays a role. A person who has Histamine Intolerance does not necessarily have an allergy and vice versa. It is extremely important to check if you have an allergy or not. It should be part of the differential diagnosis which excludes other possible causes of the symptoms you may have.
It is not necessarily so that a person who has HIT will automatically have mastocytosis. However, a person who has mastocytosis will also likely be affected by HIT.
If a person does have mastocytosis then they will automatically have to adhere to a low-histamine diet. This is a very low, low, low histamine diet that also requires a strict avoidance of foods which can cause the degranulation of mastcells. But there are many more aspects to mastocytosis than just that. People who suffer from mastocytosis have the problem that they have abnormal growth and accumulation of mast cells. Mast cells play an important role as part of the immune system. If triggered, those mastcells will release a lot of substances including histamine.
DEFINING THE CAUSE IS ESSENTIAL
The actual cause and a possible combination with other conditions determines whether a person’s HIT will disappear again or not, whether they need to take extra medication and how much histamine they actually need to avoid. A person who has had a short-term bowel infection and who has been able to treat the infection successfully has a good chance that the HIT will disappear again. A person who has a food intolerance such as lactose intolerance, fructose malabsorption or sorbitol intolerance, for example, which involves diarrhoea, will highly likely be able to get any histamine intolerance symptoms under control if they make sure they take care of the other intolerance(s) as well. A person who has an allergy and HIT will be having more severe symptoms when they have a reaction (seasonal or certain substances such as foods or drugs), but when there is no allergic reaction the HIT symptoms could also disappear (depending on the severity of HIT). A person who has some form mastocytosis will need to adhere to a very special diet for life and needs to take extra medication. These are just a few examples of what could be wrong with a person who has HIT. All those who have a diagnosis for HIT have their own situation. Some people can tolerate more histamine and some less, depending (again) on what causes it.
More about allergies and patient support groups can be found here:
American College of Allergy, Asthma & Immunology
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
EFA European Federation of Allergy and Airways Diseases Patients’ Associations
FARE Food Allergy Research & Education in the USA
Canadian Allergy, Asthma and Immunology Foundation – Fondation canadienne d’allergie, d’asthme et d’immunologie
Allergy & Anaphylaxis Australia
More about mastocytosis and patient support groups can be found here:
Current treatment options in patients with mastocytosis: status in 2015 and future perspectives
by Michel Arock, Cem Akin, Olivier Hermine and Peter Valent
Article first published online: 26 MAR 2015;DOI: 10.1111/ejh.12544
European Mastocytosis Support Networks
For the following countries with explanations in their native language
Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Spain, Sweden and United Kingdom